Calendrier des promotions Mural Oncology plc
Calendrier avancé
Graphique simple
À propos de l'entreprise Mural Oncology plc
Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.Paramètres de base
IPO date
2023-11-16
ISIN
IE000LK2BOB4
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 0 | 0 |
P/BV | 0.3886 | 10 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -54.55 | 0 |
ROE | -63.57 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | -0.0642 | 10 |
Debt/Ratio | 0.0474 | 10 |
Debt/Equity | 0.2056 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 0 | 0 |
Rentabilité Ebitda, % | -28.12 | 0 |
Rentabilité EPS, % | -27.88 | 0 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 2.46 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 2.56 $ | 0 $ | 0 $ | -3.91 % | 0 % | 0 % |
common.calendar.number_days.30d | 2.75 $ | 2.46 $ | 2.61 $ | -10.55 % | 0 % | 0 % |
common.calendar.number_days.90d | 1.03 $ | 0.9952 $ | 2.98 $ | 138.83 % | 0 % | 0 % |
common.calendar.number_days.180d | 4.47 $ | 0.9952 $ | 4.47 $ | -44.97 % | 0 % | 0 % |
common.calendar.number_days.1y | 3.15 $ | 0.9952 $ | 4.47 $ | -21.9 % | 0 % | 0 % |
common.calendar.number_days.3y | 0.9952 $ | 0.9952 $ | 6.01 $ | 247.19 % | 0 % | 0 % |
common.calendar.number_days.5y | 0.9952 $ | 0.9952 $ | 6.01 $ | 247.19 % | 0 % | 0 % |
common.calendar.number_days.10y | 0.9952 $ | 0.9952 $ | 6.01 $ | 247.19 % | 0 % | 0 % |
common.calendar.number_days.ytd | 3.66 $ | 0.9952 $ | 4.47 $ | -32.79 % | 0 % | 0 % |
Principaux propriétaires
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Ms. Caroline J. Loew Ph.D. | President, CEO & Director | 303.29k | 1971 (54 année) |
Mr. Adam D. Cutler B.A. | CFO, Principal Financial Officer & Principal Accounting Officer | 496.65k | 1975 (50 années) |
Ms. Maiken Keson-Brookes | Chief Legal Officer | N/A | 1973 (52 année) |
Mr. Justin Levine | Head of Human Resources & VP of Human Resources | N/A | |
Dr. Vicki L. Goodman M.D. | Chief Medical Officer | 578.34k | 1971 (54 année) |
Informations sur l'entreprise
Adresse: Ireland, Dublin D T, 10 Earlsfort Terrace - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.muraloncology.com
Site web: https://www.muraloncology.com